Cytokine fingerprint differences following infection and vaccination - what can we learn from COVID-19?


Journal

European cytokine network
ISSN: 1952-4005
Titre abrégé: Eur Cytokine Netw
Pays: France
ID NLM: 9100879

Informations de publication

Date de publication:
01 Feb 2024
Historique:
medline: 23 6 2024
pubmed: 23 6 2024
entrez: 23 6 2024
Statut: ppublish

Résumé

COVID-19 vaccination and acute infection result in cellular and humoral immune responses with various degrees of protection. While most studies have addressed the difference in humoral response between vaccination and acute infection, studies on the cellular response are scarce. We aimed to evaluate differences in immune response among vaccinated patients versus those who had recovered from COVID-19. This was a prospective study in a tertiary medical centre. The vaccinated group included health care workers, who had received a second dose of the BNT162b2 vaccine 30 days ago. The recovered group included adults who had recovered from severe COVID-19 infection (<94% saturation in room air) after 3-6 weeks. Serum anti-spike IgG and cytokine levels were taken at entry to the study. Multivariate linear regression models were applied to assess differences in cytokines, controlling for age, sex, BMI, and smoking status. In total, 39 participants were included in each group. The mean age was 53 ±14 years, and 53% of participants were males. Baseline characteristics were similar between the groups. Based on multivariate analysis, serum levels of IL-6 (β=-0.4, p<0.01), TNFα (β=-0.3, p=0.03), IL-8 (β=-0.3, p=0.01), VCAM-1 (β=-0.2, p<0.144), and MMP-7 (β=-0.6, p<0.01) were lower in the vaccinated group compared to the recovered group. Conversely, serum anti-spike IgG levels were lower among the recovered group (124 vs. 208 pg/mL, p<0.001). No correlation was identified between antibody level and any of the cytokines mentioned above. Recovered COVID-19 patients had higher cytokine levels but lower antibody levels compared to vaccinated participants. Given the differences, these cytokines might be of value for future research in this field.

Identifiants

pubmed: 38909356
pii: ecn.2024.0494
doi: 10.1684/ecn.2024.0494
doi:

Substances chimiques

Cytokines 0
COVID-19 Vaccines 0
Antibodies, Viral 0
BNT162 Vaccine 0
Immunoglobulin G 0
Spike Glycoprotein, Coronavirus 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-19

Auteurs

Shira Cohen Rubin (SC)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Nadav Zacks (N)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ori Wand (O)

Division of Pulmonary Medicine, Barzilai University Medical Center, Ashkelon, and Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ophir Freund (O)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Evgeni Gershman (E)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Anna Breslavsky (A)

Division of Pulmonary Medicine, Barzilai University Medical Center, Ashkelon, and Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Rotem Givoli-Vilensky (R)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Anat Tzurel Ferber (AT)

Division of Pulmonary Medicine, Barzilai University Medical Center, Ashkelon, and Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Natalya Bilenko (N)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel, Medical Office of Southern District, Ministry of Health, Ashkelon, Israel.

Amir Bar-Shai (A)

The Institute of Pulmonary Medicine, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH